抑制p53磺酸化可预防氧化性肝毒性与急性肝衰竭
研究分析了对乙酰氨基酚(APAP)诱导急性肝衰竭患者和小鼠的基因表达,构建肝特异性Papss2敲除小鼠并进行APAP诱导急性肝衰竭实验,发现PAPSS2表达降低,Papss2敲除小鼠通过p53-p21-Nrf2轴增强抗氧化能力而免受肝毒性,p53是磺酸化新底物,抑制p53磺酸化可能用于APAP过量的临床管理。
要点
- APAP诱导的急性肝衰竭患者和小鼠肝脏中PAPSS2表达降低。
- 肝特异性Papss2敲除小鼠虽APAP磺化减少,但通过p53-p21-Nrf2轴增强抗氧化能力而免受APAP肝毒性。
- p53是磺酸化新底物,Papss2缺失通过阻止p53磺酸化破坏p53-MDM2相互作用和泛素化,增加p53蛋白稳定性。
核心结论
- PAPSS2通过p53介导的机制调控氧化应激反应,抑制p53磺酸化可能用于APAP过量的临床管理。
研究设计与样本
- 分析APAP诱导急性肝衰竭患者和小鼠的基因表达,构建肝特异性Papss2敲除小鼠(Alb-Cre或AAV8-TBG-Cre),并使用原代人及小鼠肝细胞进行体外机制分析。
主要发现
- APAP诱导的急性肝衰竭患者和小鼠肝脏中PAPSS2表达降低。
- Papss2ΔHC小鼠APAP磺化减少,但通过激活p53-p21-Nrf2轴增强肝脏抗氧化能力,从而免受APAP诱导的肝毒性。
- 磺酸化抑制剂治疗也改善APAP诱导的肝毒性。
- 基因敲低实验显示Papss2ΔHC的护肝作用依赖Nrf2、p53和p21。
- Papss2缺失通过阻止p53磺酸化导致p53蛋白积累,破坏p53-MDM2相互作用和p53泛素化,增加p53蛋白稳定性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Sulfoconjugation of small molecules or protein peptides is a key mechanism to ensure biochemical and functional homeostasis in mammals. The PAPS synthase 2 (PAPSS2) is the primary enzyme to synthesize the universal sulfonate donor 3'-phosphoadenosine 5'-phosphosulfate (PAPS). Acetaminophen (APAP) overdose is the leading cause of acute liver failure (ALF), in which oxidative stress is a key pathogenic event, whereas sulfation of APAP contributes to its detoxification. The goal of this study was to determine whether and how PAPSS2 plays a role in APAP-induced ALF. METHODS: Gene expression was analyzed in APAP-induced ALF in patients and mice. Liver-specific Papss2-knockout mice using Alb-Cre (Papss2ΔHC) or AAV8-TBG-Cre (Papss2iΔHC) were created and subjected to APAP-induced ALF. Primary human and mouse hepatocytes were used for in vitro mechanistic analysis. RESULTS: The hepatic expression of PAPSS2 was decreased in APAP-induced ALF in patients and mice. Surprisingly, Papss2ΔHC mice were protected from APAP-induced hepatotoxicity despite having a decreased APAP sulfation, which was accompanied by increased hepatic antioxidative capacity through the activation of the p53-p2-Nrf2 axis. Treatment with a sulfation inhibitor also ameliorated APAP-induced hepatotoxicity. Gene knockdown experiments showed that the hepatoprotective effect of Papss2ΔHC was Nrf2, p53, and p21 dependent. Mechanistically, we identified p53 as a novel substrate of sulfation. Papss2 ablation led to p53 protein accumulation by preventing p53 sulfation, which disrupts p53-MDM2 interaction and p53 ubiquitination and increases p53 protein stability. CONCLUSIONS: We have uncovered a previously unrecognized and p53-mediated role of PAPSS2 in controlling oxidative response. Inhibition of p53 sulfation may be explored for the clinical management of APAP overdose.
引用
- Xu P, Xi Y, Wang P, et al. Inhibition of p53 Sulfoconjugation Prevents Oxidative Hepatotoxicity and Acute Liver Failure. Gastroenterology. 2021. PMID: 34954226. doi:10.1053/j.gastro.2021.12.260
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。